Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2531-2540
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2531
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2531
Table 3 Incidence of abnormal imaging findings in patients with paracoccidioidomycosis and extrahepatic cholestasis allocated to groups 1 and 2, n (%)
| Imaging finding | Group 1 | Group 2 | P value |
| n = 27 | n = 13 | ||
| Abdominal lymphadenomegaly | 21 (77.7) | 10 (76.9) | 1.000 |
| Hepatomegaly | 20 (74.0) | 7 (53.8) | 0.283 |
| Biliary dilatation | 18 (66.6) | 10 (76.9) | 0.715 |
| Splenomegaly | 4 (14.8) | 6 (46.1) | 0.052 |
| Pancreatic head mass | 3 (11.0) | 5 (38.0) | 1.000 |
- Citation: dos Santos JS, de Moura Arrais V, Rosseto Ferreira WJ, Ribeiro Correa Filho R, Brunaldi MO, Kemp R, Sankanrakutty AK, Elias Junior J, Bellissimo-Rodrigues F, Martinez R, Zangiacomi Martinez E, Ardengh JC. Extrahepatic cholestasis associated with paracoccidioidomycosis: Challenges in the differential diagnosis of biliopancreatic neoplasia. World J Gastrointest Oncol 2024; 16(6): 2531-2540
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2531.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2531